Comparison of the Bioavailability of Diclofenac in a Combination Product (Diclofenac 2% + Capsaicin 0.075% Topical Gel) With Two Diclofenac Only Products, Diclofenac Mono Gel 2% and Voltarol® 12 Hour Emulgel 2.32% Gel, in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 20, 2017

Primary Completion Date

June 29, 2017

Study Completion Date

June 29, 2017

Conditions
Healthy
Interventions
DRUG

Diclofenac Sodium

twice daily

DRUG

Diclofenac & Capsaicin

twice daily

DRUG

Diclofenac Sodium Topical Gel

twice daily

Trial Locations (1)

9301

Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY